Marinomed Biotech AG | WebDisclosure

Basculer en Français

9819	Companies
197063	Keywords
128135	Articles
104804	Press releases

Home
Companies
Marinomed Biotech AG

PRESS RELEASE

published on 09/15/2024 at 17:49, 1 year 4 months ago

EQS-Adhoc: Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory subscription rights
Marinomed Biotech AG sets price range for potential 10% capital increase and second capital increase, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Price Range Authorized Capital 2024 Restructuring Proceedings
BRIEF

published on 09/11/2024 at 07:50, 1 year 4 months ago

Marinomed Biotech AG: First Carragelose Products Receive New Medical Device Regulation (MDR) Certification

Regulatory Compliance Medical Devices Carragelose MDR Certification Marinomed
BRIEF

published on 09/11/2024 at 07:50, 1 year 4 months ago

Marinomed Biotech AG : les premiers produits à base de carraghénane reçoivent la nouvelle certification du Règlement sur les dispositifs médicaux (MDR)

Dispositifs Médicaux Conformité Réglementaire Certification MDR Marinomé Carraghénose
PRESS RELEASE

published on 09/11/2024 at 07:45, 1 year 4 months ago

Marinomed Biotech AG: First Carragelose products receive new Medical Device Regulation (MDR) certification
Marinomed Biotech AG's first Carragelose products receive new Medical Device Regulation (MDR) certification, enhancing safety and value for the portfolio

Regulatory Compliance Medical Devices Marinomed Biotech AG MDR Certification Carragelose Products
BRIEF

published on 09/02/2024 at 17:51, 1 year 5 months ago

Marinomed Biotech AG Evaluates 10% Capital Increase

Investors Shares Capital Increase Restructuring Marinomed
BRIEF

published on 09/02/2024 at 17:51, 1 year 5 months ago

Marinomed Biotech AG évalue une augmentation de capital de 10 %

Actions Augmentation De Capital Investisseurs Restructuration Marinomé
PRESS RELEASE

published on 09/02/2024 at 17:46, 1 year 5 months ago

EQS-Adhoc: Marinomed Biotech AG evaluates possible 10% capital increase with exclusion of statutory subscription rights
Marinomed Biotech AG evaluates a possible 10% capital increase excluding statutory subscription rights to finance ongoing costs in restructuring proceedings. Management Board to discuss with selected investors for potential transaction

Capital Increase Management Board Marinomed Biotech AG Restructuring Proceedings Statutory Subscription Rights
BRIEF

published on 08/20/2024 at 18:05, 1 year 5 months ago

Marinomed Biotech AG Reports Preliminary Financial Figures for H1 2024

Financial Results Product Development Restructuring Proceedings Q2 Revenue Growth New Partnerships
BRIEF

published on 08/20/2024 at 18:05, 1 year 5 months ago

Marinomed Biotech AG publie ses résultats financiers préliminaires pour le premier semestre 2024

Résultats Financiers Développement De Produits Croissance Du Chiffre D'affaires Au Deuxième Trimestre Procédure De Restructuration Nouveaux Partenariats
PRESS RELEASE

published on 08/20/2024 at 18:00, 1 year 5 months ago

Marinomed Biotech AG reports preliminary financial figures for the first half of 2024
Marinomed Biotech AG reports preliminary financial figures for the first half of 2024, including a decline in revenues compared to 2023. The company aims to stabilize through restructuring and new partnerships

Restructuring Preliminary Results Financial Figures Partnerships Marinomed Biotech AG

Accesswire

Published on 02/06/2026 at 15:30, 3 hours 26 minutes ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 5 hours 26 minutes ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/06/2026 at 13:30, 5 hours 26 minutes ago

Canex Metals Acquires 51.93% of Gold Basin and Seeks a Court-Appointed Annual General Meeting of Gold Basin Shareholders
Published on 02/06/2026 at 13:00, 5 hours 56 minutes ago

Revolve Announces US$40 Million Strategic Financing With Callaway Capital
Published on 02/06/2026 at 08:00, 10 hours 56 minutes ago

Caledonia Mining Corporation Plc Non-Executive Director Shareholding Notification

View all ACCESSWIRE

EQS Group

Published on 02/06/2026 at 17:52, 1 hour 3 minutes ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 17:40, 1 hour 16 minutes ago

Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.26.
Published on 02/06/2026 at 16:55, 2 hours ago

GAC MPV Serves as Official Reception Fleet for APEC China 2026, Demonstrating the Strength of Chinese Manufacturing
Published on 02/06/2026 at 15:25, 3 hours 30 minutes ago

CES 2026 Innovation Award Honoree iGarden M1 Pro Max Launches as World's First Bionic Dual-Vision Pool Cleaner
Published on 02/06/2026 at 15:24, 3 hours 32 minutes ago

Form 8.3 - The Vanguard Group, Inc.: NCC Group plc

Les Echos

Published on 02/06/2026 at 18:22, 33 minutes ago

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 33 minutes ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 2 hours 54 minutes ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 2 hours 54 minutes ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 11 hours 1 minute ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE